Inflawell(®) improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial
在一项随机双盲安慰剂对照临床试验中,Inflawell® 可改善中度 COVID-19 患者的中性粒细胞与淋巴细胞比率并缩短住院时间。
期刊:Inflammopharmacology
影响因子:5.3
doi:10.1007/s10787-022-00928-w
Barzin Tond, Sepideh; Balenci, Laurent; Khajavirad, Nasim; Salehi, Mohammadreza; Tafakhori, Abbas; Shahmohammadi, Mohammad Reza; Ghiasvand, Fereshteh; Jafari, Sirous; Abolghasemi, Sara; Mokhtari, Farzad; Mahmoodi Baram, Somayyeh; Zarei, Tayebe; Kazemi, Davood; Mohammadnejad, Esmaeil; Shah-Hosseini, Akram; Haghbin Toutounchi, Alireza; Fallah, Soudabeh; Riazi, Ali; Karima, Saeed